2019
Abeta34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression.
Authors:
Liebsch, F., Kulic, L., Teunissen, C., Shobo, A., Ulku, I., Engelschalt, V., Hancock, M.A., van der Flier, W.M., Kunach, P., Rosa-Neto, P.**, Scheltens, P., Poirier, J.**, Saftig, P., Bateman, R.J., Breitner, J.**, Hock, C., Multhaup, G.**
Journal:
Nature communications.
Share
Receive the
latest news
Stay updated with the latest research developments from CCNA-CCNV. Our news section provides insights into cutting-edge studies, advancements in dementia care, and key findings in brain health research.
